Effects of sodium oxybate on hypocretin/orexin and locus coeruleus neurons
SLEEP · 2023
DOI: 10.1093/sleep/zsad135 ↗Kurz gefasst
Fachartikel in der Zeitschrift SLEEP, 2023. Verfasst von Ming-Fung Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles, CA, USA. Hauptthemen laut MEDLINE: Sodium Oxybate, Cataplexy, Narcolepsy, Opiate Alkaloids. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, Jazz Pharmaceuticals, NIH.
Abstract (Originalsprache)
Long-term use of sodium oxybate (SXB), (also called gamma-hydroxybutyrate [GHB]) attenuates the cataplexy and sleepiness of human narcolepsy. We had previously found that chronic opiate usage in humans and long-term opiate administration to mice significantly increased the number of detected hypocretin/orexin (Hcrt) neurons, decreased their size, and increased Hcrt level in the hypothalamus. We also found that opiates significantly decreased cataplexy in human narcoleptics as well as in narcoleptic mice and that cessation of locus coeruleus neuronal activity preceded and was tightly linked to cataplectic attacks in narcoleptic dogs. We tested the hypothesis that SXB produces changes similar to opiates and now report that chronic SXB administration significantly increased the size of Hcrt neurons, the reverse of what we had seen with opiates in humans and mice. Levels of Hcrt in the hypothalamus were nonsignificantly lower, in contrast to the significant increase in hypothalamic Hcrt level after opiates. SXB decreased tyrosine hydroxylase levels in the locus coeruleus, the major descending projection of the hypocretin system, also the reverse of what we saw with opioids. Therefore despite some similar effects on narcoleptic symptomatology, SXB does not produce anatomical changes similar to those elicited by opiates. Analysis of changes in other links in the cataplexy pathway might further illuminate SXB’s mechanism of action on narcolepsy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
- Neurobiology Research, VA Greater Los Angeles Healthcare System, North Hills, CA, USA.
- Brain Research Institute, University of California, Los Angeles, CA, USA.
Förderung
- NIDA NIH HHS
- Jazz Pharmaceuticals
- NIH
- Medical Research Service of the Department of Veterans Affairs
Zitieren
APA
Wu, M. F., Thannickal, T. C., Li, S., McGregor, R., Lai, Y. Y., & Siegel, J. M. (2023). Effects of sodium oxybate on hypocretin/orexin and locus coeruleus neurons. SLEEP. https://doi.org/10.1093/sleep/zsad135
Vancouver
Wu MF, Thannickal TC, Li S, McGregor R, Lai YY, Siegel JM. Effects of sodium oxybate on hypocretin/orexin and locus coeruleus neurons. SLEEP. 2023. doi:10.1093/sleep/zsad135
BibTeX
@article{Wu2023,
author = {Wu, Ming-Fung and Thannickal, Thomas C and Li, Songlin and McGregor, Ronald and Lai, Yuan-Yang and Siegel, Jerome M},
title = {Effects of sodium oxybate on hypocretin/orexin and locus coeruleus neurons},
journal = {SLEEP},
year = {2023},
doi = {10.1093/sleep/zsad135}
}
EUVIMED